Skip to main content
Log in

In dialogue with the NIH on clinical trials policy

  • Q&A
  • Published:

From Nature Human Behaviour

View current issue Submit your manuscript

In his capacity as immediate past president of the Federation of Associations of Behavioral and Brain Sciences, Jeremy Wolfe interviews Mike Lauer about the new NIH clinical trials policy. Mike Lauer is NIH’s deputy director for extramural research, serving as the principal scientific leader and advisor to the NIH director on the extramural research programme.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeremy M. Wolfe.

Ethics declarations

Competing interests

J.M.W. is currently funded by the NIH. He does not have any current advisory role with the NIH though he has previously served as a grant reviewer and study section member. He has no involvement in setting the clinical trial policy changes or their implementation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wolfe, J.M. In dialogue with the NIH on clinical trials policy. Nat Hum Behav 2, 100–102 (2018). https://doi.org/10.1038/s41562-018-0303-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41562-018-0303-x

  • Springer Nature Limited

This article is cited by

Navigation